Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Rogers

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Bioorganic & Medicinal Chemistry Letters|February 6, 2013
Highly potent and selective cannabinoid receptor 2 agonists: initial hit optimization of an adamantyl hit series identified from high-through-put screeningMatthias Nettekoven, Jürgen Fingerle, Uwe Grether, et al.
BMC Biology|December 24, 2015
iCLIP identifies novel roles for SAFB1 in regulating RNA processing and neuronal functionCaroline Rivers, Jalilah Idris, Helen Scott, et al.
International Journal of Cancer|September 23, 2006
Urinary biomarker profiling in transitional cell carcinomaNicholas P Munro, David A Cairns, Paul Clarke, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 28, 2004
Subclinical bovine spongiform encephalopathy infection in transgenic mice expressing porcine prion proteinJoaquín Castilla, Alfonso Gutiérrez-Adán, Alejandro Brun, et al.
Angewandte Chemie (International Ed. in English)|May 10, 2008
Spirocyclic oxetanes: synthesis and propertiesGeorg Wuitschik, Mark Rogers-Evans, Andreas Buckl, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 20, 2016
Disability Rating Scales in Parkinson's Disease: Critique and RecommendationsLisa M Shulman, Melissa Armstrong, Terry Ellis, et al.
Journal of Medicinal Chemistry|January 18, 2020
Discovery of Balovaptan, a Vasopressin 1a Receptor Antagonist for the Treatment of Autism Spectrum DisorderPatrick Schnider, Caterina Bissantz, Andreas Bruns, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2008
Prognostic factors in renal cell carcinoma: association of preoperative sodium concentration with survivalNaveen S Vasudev, Janet E Brown, Sarah R Brown, et al.
Muscle & Nerve|October 21, 2017
Chronic pain has a strong impact on quality of life in facioscapulohumeral muscular dystrophyGermán Morís, Libby Wood, Roberto FernáNdez-Torrón, et al.
Molecules (Basel, Switzerland)|September 22, 2019
Selective Cannabinoid 2 Receptor Agonists as Potential Therapeutic Drugs for the Treatment of Endotoxin-Induced UveitisRichard Frederick Porter, Anna-Maria Szczesniak, James Thomas Toguri, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry Letters|February 6, 2013
Highly potent and selective cannabinoid receptor 2 agonists: initial hit optimization of an adamantyl hit series identified from high-through-put screeningMatthias Nettekoven, Jürgen Fingerle, Uwe Grether, et al.
BMC Biology|December 24, 2015
iCLIP identifies novel roles for SAFB1 in regulating RNA processing and neuronal functionCaroline Rivers, Jalilah Idris, Helen Scott, et al.
International Journal of Cancer|September 23, 2006
Urinary biomarker profiling in transitional cell carcinomaNicholas P Munro, David A Cairns, Paul Clarke, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 28, 2004
Subclinical bovine spongiform encephalopathy infection in transgenic mice expressing porcine prion proteinJoaquín Castilla, Alfonso Gutiérrez-Adán, Alejandro Brun, et al.
Angewandte Chemie (International Ed. in English)|May 10, 2008
Spirocyclic oxetanes: synthesis and propertiesGeorg Wuitschik, Mark Rogers-Evans, Andreas Buckl, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 20, 2016
Disability Rating Scales in Parkinson's Disease: Critique and RecommendationsLisa M Shulman, Melissa Armstrong, Terry Ellis, et al.
Journal of Medicinal Chemistry|January 18, 2020
Discovery of Balovaptan, a Vasopressin 1a Receptor Antagonist for the Treatment of Autism Spectrum DisorderPatrick Schnider, Caterina Bissantz, Andreas Bruns, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2008
Prognostic factors in renal cell carcinoma: association of preoperative sodium concentration with survivalNaveen S Vasudev, Janet E Brown, Sarah R Brown, et al.
Muscle & Nerve|October 21, 2017
Chronic pain has a strong impact on quality of life in facioscapulohumeral muscular dystrophyGermán Morís, Libby Wood, Roberto FernáNdez-Torrón, et al.
Molecules (Basel, Switzerland)|September 22, 2019
Selective Cannabinoid 2 Receptor Agonists as Potential Therapeutic Drugs for the Treatment of Endotoxin-Induced UveitisRichard Frederick Porter, Anna-Maria Szczesniak, James Thomas Toguri, et al.
Pageof 8